Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
Abstract Background Although neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol and phenoba...
Saved in:
Main Authors: | Tamorah Lewis (Author), Simisola Kuye (Author), Ashley Sherman (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014) -
Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
by: Briley Annette, et al.
Published: (2009) -
Phenobarbital in Neonatal Seizures
by: J Gordon Millichap
Published: (1993) -
Safety of Phenobarbital in Neonates with HIE
by: J Gordon Millichap
Published: (1994) -
Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
by: Olesya V. Zakharova
Published: (2024)